Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
George Nesr, Raakhee Shah, Charalampia Kyriakou, Jonathan Sive, Rakesh Popat, Kwee Yong, Brendan Wisniowski, Ke Xu, Ashu Wechalekar, Lydia Lee, Stuart Ings, Xenofon Papanikolaou, Shameem Mahmood, Annabel Mcmillan, Jackie Horder, Fiona Newrick, Jotham Marfil, Louise Ainley, Samir Asher, Simon Cheesman & Neil Rabin. (2023) Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience. Leukemia & Lymphoma 64:8, pages 1465-1471.
Read now
Read now
Jie Duan, Ligang Chen, Jiao Tu, Li Cao & Xiao Xiao. (2022) Folate-grafted glycyl-glycine-melphalan conjugate self-assembled amphilphilc nanomicelles augmented drug delivery, cytotoxicity and cellular uptake in human ovarian cancer cells. Journal of Microencapsulation 39:3, pages 197-209.
Read now
Read now
Articles from other publishers (35)
Yingcong Wang, Sanfeng Dong, Ke Hu, Li Xu, Qilin Feng, Bo Li, Guangli Wang, Gege Chen, Bibo Zhang, Xinyan Jia, Zhijian Xu, Xuejie Gao, Hui Zhang, Yongsheng Xie, Meiling Lu, Shuaikang Chang, Dongliang Song, Xiaosong Wu, Qi Jia, Huabin Zhu, Jinfeng Zhou, Weiliang Zhu & Jumei Shi. (2023) The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway. Journal of Translational Medicine 21:1.
Crossref
Crossref
M. Asencio-Durán, E. Fernández-Gutiérrez, M. Larrañaga-Cores, C. Klein-Burgos, J.V. Dabad-Moreno & M. Capote-Díez. (2023) Ocular side effects of oncological therapies: Review. Archivos de la Sociedad Española de Oftalmología (English Edition).
Crossref
Crossref
M. Asencio-Durán, E. Fernández-Gutiérrez, M. Larrañaga-Cores, C. Klein-Burgos, J.V. Dabad-Moreno & M. Capote-Díez. (2023) Efectos secundarios oculares de las terapias oncológicas. Revisión. Archivos de la Sociedad Española de Oftalmología.
Crossref
Crossref
Yingying Chen, Qiang Zeng, Bingyang Chu, Zhigang Liu, Xue Wei, Mengran Chen, Peipei Yang, Minghai Tang, Ting Niu, Yongqian Jia, Ying Qu & Zhiyong Qian. (2023) Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma. Chinese Chemical Letters 34:9, pages 108133.
Crossref
Crossref
Bruno Almeida Costa, Tarek H. Mouhieddine, Ricardo J. Ortiz & Joshua Richter. (2023) Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives. Critical Reviews in Oncology/Hematology 187, pages 104040.
Crossref
Crossref
Sanwang Li:Yikun Wang, Bikui Zhang & Hualin Cai. (2023) A rapid and sensitive LC-MS/MS method for simultaneous determination of melphalan and its monohydroxy and dihydroxy metabolites in human plasma. Journal of Chromatography B, pages 123698.
Crossref
Crossref
Abdullah M. Khan, Filiz Yucebay, Qiuhong Zhao, Elvira Umyarova, Francesca Cottini, Naresh Bumma, Ashley Rosko, Don Benson, Nidhi Sharma, Yvonne Efebera & Srinivas Devarakonda. (2023) Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 23:2, pages e85-e96.
Crossref
Crossref
Sara Ovejero, Elena Viziteu, Laure Dutrieux, Julie Devin, Yea-Lih Lin, Elina Alaterre, Michel Jourdan, Jihane Basbous, Guilhem Requirand, Nicolas Robert, Hugues de Boussac, Anja Seckinger, Dirk Hose, Laure Vincent, Charles Herbaux, Angelos Constantinou, Philippe Pasero & Jérôme Moreaux. (2022) The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. Frontiers in Immunology 13.
Crossref
Crossref
Archna Panghal, Chittaranjan Sahu, Shivani Singla & Gopabandhu Jena. (2022) Juvenile exposure and adult risk assessment with single versus repeated exposure of melphalan in the germ cells of male SD rat: Deciphering the molecular mechanisms. Reproductive Toxicology 113, pages 71-84.
Crossref
Crossref
Rakesh Pahwa, Jatin Chhabra, Raj Kumar & Rakesh Narang. (2022) Melphalan: Recent insights on synthetic, analytical and medicinal aspects. European Journal of Medicinal Chemistry 238, pages 114494.
Crossref
Crossref
Firoozeh Abolhasani Zadeh, Saade Abdalkareem Jasim, Mohammad Javed Ansari, Dmitry Olegovich Bokov, Ghulam Yasin, Lakshmi Thangavelu & Maryam Derakhshandeh. (2022) Boron carbide nanotube as targeted drug delivery system for melphalan anticancer drug. Journal of Molecular Liquids 354, pages 118796.
Crossref
Crossref
Marjan Khorsand, Sahar Khajeh, Mahboobeh Eslami, Navid Nezafat, Younes Ghasemi, Vahid Razban & Zohreh Mostafavi‐Pour. (2022) Telmisartan anti‐cancer activities mechanism through targeting N‐cadherin by mimicking ADH‐1 function. Journal of Cellular and Molecular Medicine 26:8, pages 2392-2403.
Crossref
Crossref
Ken Flanagan, Romika Kumari, Juho J. Miettinen, Staci L. Haney, Michelle L. Varney, Jacob T. Williams, Muntasir M. Majumder, Minna Suvela, Ana Slipicevic, Fredrik Lehmann, Nina N. Nupponen, Sarah A. Holstein & Caroline A. Heckman. (2022) The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death. HemaSphere 6:3, pages e687.
Crossref
Crossref
Monica Epstein & Candis Morrison. (2022) Practical guidance for new multiple myeloma treatment regimens: A nursing perspective. Seminars in Oncology 49:1, pages 103-117.
Crossref
Crossref
Ehsan Shakerzadeh. (2021)
Endohedral M@B
40
(M = Na and Ca) metalloborospherenes as innovative potential carriers for chemotherapy melphalan drug: A theoretical study
. Applied Organometallic Chemistry 35:12.
Crossref
Crossref
Anna Y. Aksenova, Anna S. Zhuk, Artem G. Lada, Irina V. Zotova, Elena I. Stepchenkova, Ivan I. Kostroma, Sergey V. Gritsaev & Youri I. Pavlov. (2021) Genome Instability in Multiple Myeloma: Facts and Factors. Cancers 13:23, pages 5949.
Crossref
Crossref
J. Runnels, G. Acosta, A. Rose, M. Haynes, D. Nikolaidis, A. Wong & B. Fiani. (2021) The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clinical and Translational Oncology 23:10, pages 2066-2077.
Crossref
Crossref
Christian A. Celaya, Luis Felipe Hernández-Ayala, Fernando Buendía Zamudio, Jorge A. Vargas & Miguel Reina. (2021) Adsorption of melphalan anticancer drug on C24, B12N12, B12C6N6, B6C12N12 and B6C6N12 nanocages: A comparative DFT study. Journal of Molecular Liquids 329, pages 115528.
Crossref
Crossref
Anastazja Poczta, Aneta Rogalska & Agnieszka Marczak. (2021) Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches. Journal of Clinical Medicine 10:9, pages 1841.
Crossref
Crossref
Michał Bohdan, Anna Kowalczys, Agnieszka Mickiewicz, Marcin Gruchała & Ewa Lewicka. (2021) Cancer Therapy-Related Cardiovascular Complications in Clinical Practice: Current Perspectives. Journal of Clinical Medicine 10:8, pages 1647.
Crossref
Crossref
Quan He, Cuirong Sun, Jian Liu & Yuanjiang Pan. (2021) MALDI-MSI analysis of cancer drugs: Significance, advances, and applications. TrAC Trends in Analytical Chemistry 136, pages 116183.
Crossref
Crossref
Sara Ovejero & Jerome Moreaux. (2021) Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. Exploration of Targeted Anti-tumor Therapy.
Crossref
Crossref
Grace Lassiter, Cole Bergeron, Ryan Guedry, Julia Cucarola, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath & Ivan Urits. (2021) Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Current Oncology 28:1, pages 640-660.
Crossref
Crossref
Ada Hang-Heng Wong, Eun Myoung Shin, Vinay Tergaonkar & Wee-Joo Chng. (2020) Targeting NF-κB Signaling for Multiple Myeloma. Cancers 12:8, pages 2203.
Crossref
Crossref
Wenxiao Jiang, Jun Xia, Shangdan Xie, Ruanmin Zou, Shuya Pan, Zhi-wei Wang, Yehuda G. Assaraf & Xueqiong Zhu. (2020) Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resistance Updates 50, pages 100683.
Crossref
Crossref
Yingcong Wang, Jing Huang, Bo Li, Han Xue, Guido Tricot, Liangning Hu, Zhijian Xu, Xiaoxiang Sun, Shuaikang Chang, Lu Gao, Yi Tao, Hongwei Xu, Yongsheng Xie, Wenqin Xiao, Dandan Yu, Yuanyuan Kong, Gege Chen, Xi Sun, Fulin Lian, Naixia Zhang, Xiaosong Wu, Zhiyong Mao, Fenghuang Zhan, Weiliang Zhu & Jumei Shi. (2020) A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression. Cancer Research 80:3, pages 536-548.
Crossref
Crossref
Dimitrios Trafalis, Panagiotis Dalezis, Elena Geromichalou, Sofia Sagredou, Eleni Sflakidou, Maria Voura, Margarita Grammatikopoulou, Catherine Gabriel & Vasiliki Sarli. (2020)
Discovery of steroidal lactam conjugates of POPAM-NH
2
with potent anticancer activity
. Future Medicinal Chemistry 12:1, pages 19-35.
Crossref
Crossref
SABINE KARAM, VICTORIA GUTGARTS & ILYA GLEZERMAN. 2020. Onco-Nephrology. Onco-Nephrology
183
196.e7
.
Karen Sweiss, Gregory S. Calip, Jeremy J. Johnson, Damiano Rondelli & Pritesh R. Patel. (2019) Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma. Bone Marrow Transplantation 54:12, pages 2081-2087.
Crossref
Crossref
Benjamin Diethelm-Varela, Yong Ai, Dongdong Liang & Fengtian Xue. (2019) Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends. Current Topics in Medicinal Chemistry 19:9, pages 691-712.
Crossref
Crossref
Urvi A. Shah, Sengottuvel Viswanathan, Beamon Agarwal, Aditi Shastri, Ioannis Mantzaris, Murali Janakiram, Noah Kornblum, Ira Braunschweig, Amit Verma, Yang Shi, John Reinus & Olga Derman. (2018) Sinusoidal Obstruction Syndrome (SOS) in Multiple Myeloma with Renal Failure. Case Reports in Oncological Medicine 2018, pages 1-6.
Crossref
Crossref
Weilong Zhang, Yuansheng Lin, Xiaoni Liu, Xue He, Ye Zhang, Wei Fu, Zuozhen Yang, Ping Yang, Jing Wang, Kai Hu, Xiuru Zhang, Weiyou Liu, Xiaoliang Yuan & Hongmei Jing. (2018) Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma. Journal of Translational Medicine 16:1.
Crossref
Crossref
Pawel Robak, Izabela Drozdz, Janusz Szemraj & Tadeusz Robak. (2018) Drug resistance in multiple myeloma. Cancer Treatment Reviews 70, pages 199-208.
Crossref
Crossref
Xia Cheng, Guoliang Zhang, Raina Seupel, Doris Feineis, Daniela Brünnert, Manik Chatterjee, Andreas Schlosser & Gerhard Bringmann. (2018) Epoxides related to dioncoquinone B: Synthesis, activity against multiple myeloma cells, and search for the target protein. Tetrahedron 74:38, pages 5102-5112.
Crossref
Crossref
Java Walladbegi, Sarah A. Smith, Amy K. Grayson, Craig Murdoch, Mats Jontell & Helen E. Colley. (2018) Cooling of the oral mucosa to prevent adverse effects of chemotherapeutic agents: An in vitro study. Journal of Oral Pathology & Medicine 47:5, pages 477-483.
Crossref
Crossref